18 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; and
exemptions from … the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements.
We may take advantage
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; and
exemptions from … the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements.
We may take advantage
10-K
2023 FY
EX-97.1
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
(or clawback) of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; and
exemptions from … the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements.
We may take advantage
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
CONDITION AND RESULTS OF OPERATIONS
BUSINESS
MANAGEMENT
EXECUTIVE COMPENSATION
CERTAIN RELATIONSHIPS AND RELATED PARTY AND OTHER TRANSACTIONS
PRINCIPAL … Act”);
reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements
424B4
0np pd9suic
20 Feb 24
Prospectus supplement with pricing info
5:28pm
DRS/A
4ey2pp
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next